Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Other Operating Expenses (2016 - 2018)

Cardiff Oncology (CRDF) has disclosed Other Operating Expenses for 7 consecutive years, with $26677.0 as the latest value for Q3 2018.

  • Quarterly Other Operating Expenses fell 94.36% to $26677.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $26677.0 through Jun 2019, down 98.17% year-over-year, with the annual reading at -$28244.0 for FY2020, 1527.91% down from the prior year.
  • Other Operating Expenses hit $26677.0 in Q3 2018 for Cardiff Oncology, down from $204436.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.5 million in Q4 2014 to a low of $26677.0 in Q3 2018.
  • Historically, Other Operating Expenses has averaged $1.7 million across 5 years, with a median of $2.0 million in 2015.
  • Biggest five-year swings in Other Operating Expenses: surged 657.43% in 2014 and later crashed 94.36% in 2018.
  • Year by year, Other Operating Expenses stood at $4.5 million in 2014, then tumbled by 52.27% to $2.1 million in 2015, then soared by 39.79% to $3.0 million in 2016, then crashed by 86.13% to $413764.0 in 2017, then tumbled by 93.55% to $26677.0 in 2018.
  • Business Quant data shows Other Operating Expenses for CRDF at $26677.0 in Q3 2018, $204436.0 in Q2 2018, and $366344.0 in Q1 2018.